Our website uses cookies. We use cookies to remember settings and to help provide you with the best experience we can. We also use cookies to continuously improve our website by compiling visitor statistics. Read more about cookies

Inge van der Sluis

Pediatric oncologist
--
  • DNA-incorporated thioguanine to detect potential non-adherence to maintenance therapy in acute lymphoblastic leukemia

    • dec. 2025
    • Mathilde Rønne, Koch, et al
    • Cancer chemotherapy and pharmacology
  • Therapeutic drug monitoring in the treatment of childhood acute lymphoblastic leukemia – A practical guideline

    • jun. 2025
    • Miguel, Vieira Martins, et al
    • EJC Paediatric Oncology
  • KMT2A-rearranged acute lymphoblastic leukemia in infants

    • apr. 2025
    • Janine, Stutterheim, et al
    • Haematologica
  • A Refined Population Pharmacokinetic Model-Based Guideline for Individualized PEGasparaginase Dosing in Pediatric Acute Lymphoblastic Leukemia

    • apr. 2025
    • Leiah J., Brigitha, et al
    • Therapeutic Drug Monitoring
  • Walking inability in children during early treatment of acute lymphoblastic leukaemia

    • apr. 2025
    • Emma, den Hartog, et al
    • Supportive Care in Cancer
View all publications